414 related articles for article (PubMed ID: 26141929)
1. Relationship between red blood cell transfusion requirements and severity of renal disease during the acute stage of hemolytic uremic syndrome.
Cobeñas CJ; Bresso PS; Lombardi LL; Amoreo OR; Ruscasso JD; Spizzirri AP; Del C Suarez Â; Zalba JH; Rahman RC; Risso P
Pediatr Nephrol; 2015 Dec; 30(12):2115-9. PubMed ID: 26141929
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietin in children with hemolytic uremic syndrome: a pilot randomized controlled trial.
Balestracci A; Capone MA; Meni Battaglia L; Toledo I; Martin SM; Beaudoin L; Balbaryski J; Gómez L
Pediatr Nephrol; 2022 Oct; 37(10):2383-2392. PubMed ID: 35166922
[TBL] [Abstract][Full Text] [Related]
3. Postdiarrheal hemolytic uremic syndrome in Egyptian children: An 11-year single-center experience.
Eid R; Bakr A; Elmougy A; Zedan MM; Allam NA; Sarhan A; Hammad A; El-Refaey AM; Hamdy N
Saudi J Kidney Dis Transpl; 2020; 31(6):1376-1387. PubMed ID: 33565450
[TBL] [Abstract][Full Text] [Related]
4. Early erythropoietin reduced the need for red blood cell transfusion in childhood hemolytic uremic syndrome: a randomized prospective pilot trial.
Pape L; Ahlenstiel T; Kreuzer M; Drube J; Froede K; Franke D; Ehrich JH; Haubitz M
Pediatr Nephrol; 2009 May; 24(5):1061-4. PubMed ID: 19085014
[TBL] [Abstract][Full Text] [Related]
5. Early erythropoietin in post-diarrheal hemolytic uremic syndrome: a case-control study.
Balestracci A; Martin SM; Toledo I; Alvarado C; Wainsztein RE
Pediatr Nephrol; 2015 Feb; 30(2):339-44. PubMed ID: 25138373
[TBL] [Abstract][Full Text] [Related]
6. Red Blood Cell Transfusion in Patients With Autoantibodies: Is It Effective and Safe Without Increasing Hemolysis Risk?
Park SH; Choe WH; Kwon SW
Ann Lab Med; 2015 Jul; 35(4):436-44. PubMed ID: 26131416
[TBL] [Abstract][Full Text] [Related]
7. Incidence and index of severity of hemolytic uremic syndrome in a 26 year period in Fukushima Prefecture, Japan.
Kawasaki Y; Suyama K; Maeda R; Yugeta E; Takano K; Suzuki S; Sakuma H; Nemoto K; Sato T; Nagasawa K; Hosoya M
Pediatr Int; 2014 Feb; 56(1):77-82. PubMed ID: 23937579
[TBL] [Abstract][Full Text] [Related]
8. Effect of Transfusion of Red Blood Cells With Longer vs Shorter Storage Duration on Elevated Blood Lactate Levels in Children With Severe Anemia: The TOTAL Randomized Clinical Trial.
Dhabangi A; Ainomugisha B; Cserti-Gazdewich C; Ddungu H; Kyeyune D; Musisi E; Opoka R; Stowell CP; Dzik WH
JAMA; 2015 Dec; 314(23):2514-23. PubMed ID: 26637812
[TBL] [Abstract][Full Text] [Related]
9. Clinical and Laboratory Consequences of Platelet Transfusion in Shiga Toxin-Mediated Hemolytic Uremic Syndrome.
Beneke J; Sartison A; Kielstein JT; Haller H; Nitschke M; Kunzendorf U; Loos S; Kemper MJ; Stahl RA; Menne J;
Transfus Med Rev; 2017 Jan; 31(1):51-55. PubMed ID: 27468945
[TBL] [Abstract][Full Text] [Related]
10. Impact of platelet transfusions in children with post-diarrheal hemolytic uremic syndrome.
Balestracci A; Martin SM; Toledo I; Alvarado C; Wainsztein RE
Pediatr Nephrol; 2013 Jun; 28(6):919-25. PubMed ID: 23386110
[TBL] [Abstract][Full Text] [Related]
11. Complement activation is associated with more severe course of diarrhea-associated hemolytic uremic syndrome, a preliminary study.
Karnisova L; Hradsky O; Blahova K; Fencl F; Dolezel Z; Zaoral T; Zieg J
Eur J Pediatr; 2018 Dec; 177(12):1837-1844. PubMed ID: 30251107
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune hemolytic anemia in hospitalized patients: 450 patients and their red blood cell transfusions.
Chen C; Wang L; Han B; Qin L; Ying B
Medicine (Baltimore); 2020 Jan; 99(2):e18739. PubMed ID: 31914091
[TBL] [Abstract][Full Text] [Related]
13. Laboratory predictors of acute dialysis in hemolytic uremic syndrome.
Balestracci A; Martin SM; Toledo I; Alvarado C; Wainsztein RE
Pediatr Int; 2014 Apr; 56(2):234-9. PubMed ID: 24266872
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and long-term outcome of diarrhea-associated hemolytic uremic syndrome: a single center experience.
Ninchoji T; Nozu K; Nakanishi K; Horinouchi T; Fujimura J; Yamamura T; Minamikawa S; Ishimori S; Nakanishi K; Yoshikawa N; Morioka I; Kaito H; Iijima K
Clin Exp Nephrol; 2017 Oct; 21(5):889-894. PubMed ID: 28074307
[TBL] [Abstract][Full Text] [Related]
15. The hemolytic-uremic syndrome.
Brasher C; Siegler RL
West J Med; 1981 Mar; 134(3):193-7. PubMed ID: 7269554
[TBL] [Abstract][Full Text] [Related]
16. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.
Van Geet C; Proesmans W; Arnout J; Vermylen J; Declerck PJ
Kidney Int; 1998 Oct; 54(4):1324-30. PubMed ID: 9767551
[TBL] [Abstract][Full Text] [Related]
17. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
[TBL] [Abstract][Full Text] [Related]
18. [Severe course of typical hemolytic-uremic syndrome in a 14-year-old boy].
Adamczuk D; Ziołkowska H; Leszczyńska B; Roszkowska-Blaim M
Pol Merkur Lekarski; 2009 Apr; 26(154):340-2. PubMed ID: 19580203
[TBL] [Abstract][Full Text] [Related]
19. Consequences of hemolytic uremic syndrome among hemodialysis patients.
Brunelli SM; Claxton A; Mehta S; Anum EA
J Nephrol; 2015 Jun; 28(3):361-7. PubMed ID: 25491936
[TBL] [Abstract][Full Text] [Related]
20. Nonenteropathic hemolytic uremic syndrome: the experience of a medical center.
Chen SY; Wu CY; Tsai IJ; Tsau YK; Su YT
Pediatr Neonatol; 2011 Apr; 52(2):73-7. PubMed ID: 21524626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
